Publicacions en què col·labora amb Gregory Y.H. Lip (232)

2026

  1. A comparative analysis of HAS-BLED, ORBIT, DOAC, and AF-BLEED bleeding-risk scores in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia atrial fibrillation project III (MAFP-III) cohort

    Journal of Thrombosis and Haemostasis, Vol. 24, Núm. 2, pp. 431-442

  2. Atherogenic Index of Plasma and Residual Risk in Anticoagulated Patients With Atrial Fibrillation: The Prospective Murcia Atrial Fibrillation Project III Cohort

    Journal of the American Heart Association, Vol. 15, Núm. 6, pp. e046694

  3. Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry

    European Journal of Internal Medicine, Vol. 145

  4. Integrated care management for older multimorbid patients with atrial fibrillation: Rationale, design and baseline characteristics for the atrial fibrillation integrated approach in frail, multimorbid and polymedicated older people (AFFIRMO) trial

    American Heart Journal, Vol. 295

  5. Phenotype-guided risk stratification in anticoagulated atrial fibrillation patients: Cluster analysis of the Murcia AF Project III (MAFP-III)

    Heart Rhythm, Vol. 23, Núm. 3, pp. 563-574

  6. Physical activity in patients with atrial fibrillation and adverse outcomes: results from a large-scale prospective multicenter European cohort

    Revista Espanola de Cardiologia, Vol. 79, Núm. 2, pp. 151-164

  7. Prognostic value of adiposity indices in anticoagulated patients with atrial fibrillation: the prospective Murcia AF Project III cohort

    American Journal of Clinical Nutrition, Vol. 123, Núm. 3

  8. Relation of the stress hyperglycaemia ratio to residual risk in anticoagulated patients with atrial fibrillation: A report from the prospective Murcia AF Project III cohort

    Diabetes, Obesity and Metabolism, Vol. 28, Núm. 2, pp. 1431-1442

  9. The 'Atrial Fibrillation Better Care' Pathway for Integrated Care of Atrial Fibrillation: A Systematic Review and Meta-Analysis

    Thrombosis and Haemostasis

2025

  1. Association between baseline adherence to a healthy lifestyle with ischemic and major cardiovascular events in patients with atrial fibrillation

    European Journal of Preventive Cardiology

  2. Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) Classification

    Clinical Cardiology, Vol. 48, Núm. 8

  3. Frailty increases the risk of hospitalization for atrial fibrillation in older adults: a population-based cohort study

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 35, Núm. 11

  4. Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry

    Journal of the American Heart Association, Vol. 14, Núm. 1, pp. e030499

  5. Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation

    Journal of Nutrition, Health and Aging, Vol. 29, Núm. 1

  6. Relation of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio to residual risk in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF Project III cohort

    Cardiovascular Diabetology, Vol. 24, Núm. 1

  7. Remnant–to–LDL cholesterol discordance as a predictor of thromboembolic events in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF project III (MAFP-III) cohort study

    Cardiovascular Diabetology, Vol. 24, Núm. 1

  8. The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study

    Clinical cardiology, Vol. 48, Núm. 2, pp. e70102

  9. The triglyceride-glucose index, a marker of insulin resistance, as a predictor of thrombotic risk in atrial fibrillation

    Cardiovascular Diabetology, Vol. 24, Núm. 1

2024

  1. Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients

    Revista Espanola de Cardiologia, Vol. 77, Núm. 10, pp. 835-842

  2. Endothelial activation, Cell-Cell Interactions, and Inflammatory Pathways in Postoperative Atrial Fibrillation Following Cardiac Surgery.

    Biomedical Journal, pp. 100821